Darier’s disease (DD) is an autosomal dominant dermatosis characterized by hyperkeratotic papules that are mainly located in the seborrheic areas and pushups, handheld wells, and nails. The disease often appears at a young age, typically by the third decade, with no sex predilection. There is currently no standard therapy and there are usually topical palliative therapies. We present the case of an affected 42-year-old woman treated with radiation therapy for early breast cancer. Before the radiotherapy, the patient showed hyperkeratotic, brownish papules extending in a linear pattern for the neck to the abdomen, especially on both breasts and inframammary area. During the radiation, she developed grade 1 to 2 dermatitis in the irradiated area. At a followup of 6 months, the patient has no skin lesions in the irradiated zone. This report suggests that the radiotherapy is not contraindicated and may indeed be effective in local control of skin lesions in DD. 1. Introduction Darier’s disease (DD), also known as Darier-White disease [1], Dyskeratosis follicularis [2], and keratosis follicularis [3], is an autosomal dominant dermatosis characterized by hyperkeratotic papules that are particularly dense in the seborrheic areas and flexures, palmar pits, and nail dystrophy. Darier’s disease affects both men and women and is not contagious. The disease often appears at a young age, typically by the third decade, with no sex predilection. It is considered a rare disease because its prevalence in the world is estimated to be between 1?:?30.000 and 1?:?100.000. It most commonly affects the chest, neck, back, ears, and groin but may involve other body areas. The rash associated with Darier’s disease often has a distinct odour. Palms and soles may become thickened, and intraoral papules can be found. Finger nails become fragile, and this helps in diagnosis of the disease. The rash can be aggravated by heat, humidity, and exposure to sunlight. In some cases, sunlight makes it better, especially in the forehead. About etiopathogenesis, it was reported that mutations in the gene AT-P2A2, located on chromosome 12q23-24.1, cause DD [4]. It seems likely that the mutation interferes with the normal internal calcium signalling that regulates processes such as cell proliferation, differentiation, and adhesion between keratinocytes [5]. This defect in intracellular calcium regulation justifies histological features, including dyskeratosis, suprabasal acantholysis, and papillomatosis. DD is difficult to treat. A variety of palliative medical therapies exist as topical
References
[1]
Rapini, P. Ronald, and L. Bolognia Jean, Dermatology: 2-Volume Set, Mosby, St. Louis, Mo, USA, 2007.
[2]
I. M. Freedberg, A. Z. Eisen, K. Wolff, et al., Fitzpatrick’s Dermatology in General Medicine, McGraw-Hill, 6th edition, 2004.
[3]
J. William, T. Berger, and D. Elston, Adrews’ Disease of the Skin: Clinical Dermatology, Saunders, 10 edition, 2005.
[4]
A. Sakuntabhai, V. Ruiz-Perez, S. Carter et al., “Mutations in ATP2A2, encoding a Ca2+ pump, cause Darier disease,” Nature Genetics, vol. 21, no. 3, pp. 271–277, 1999.
[5]
M. Gilaberte, L. Puig, D. Vidal, and A. Alomar, “Acantholitic dyskeratotic naevi following Blaschko’s lines: a mosaic form of Darier’s disease,” Journal of the European Academy of Dermatology, vol. 150, pp. 652–657, 2004.
[6]
S. Burge, “Management of Darier’s disease,” Clinical and Experimental Dermatology, vol. 24, pp. 53–56, 1999.
[7]
S. M. Burge and P. K. Buxton, “Topical isotretinoin in Darier's disease,” British Journal of Dermatology, vol. 133, no. 6, pp. 924–928, 1995.
[8]
C. G. Burkhart and C. N. Brukhart, “Tazarotene gel for Darier's disease,” Journal of the American Academy of Dermatology, vol. 38, no. 6, pp. 1001–1002, 1998.
[9]
C. Beier and R. Kaufmann, “Efficacy of erbium:YAG laser ablation in Darier disease and Hailey- Hailey disease,” Archives of Dermatology, vol. 135, no. 4, pp. 423–427, 1999.
[10]
I. Sarkany, “Grenz-ray treatment of familial benign chronic pemphigus,” The British Journal of Dermatology, vol. 71, pp. 247–252, 1959.
[11]
D. E. Roos and C. M. Reid, “Benign familial pemphigus: little benefit from superficial radiotherapy,” Australasian Journal of Dermatology, vol. 43, no. 4, pp. 305–308, 2002.
[12]
D. Exadaktylou, H. A. Kurwa, E. Calonje, and R. J. Barlow, “Treatment of Darier's disease with photodynamic therapy,” British Journal of Dermatology, vol. 149, no. 3, pp. 606–610, 2003.
[13]
M. P. Mac Manus, G. Cavalleri, D. L. Ball, M. Beasley, H. Rotstein, and M. J. McKay, “Exacerbation, then clearance, of mutation-proven Darier's disease of the skin after radiotherapy for bronchial carcinoma: a case of radiation-induced epidermal differentiation?” Radiation Research, vol. 156, no. 6, pp. 724–730, 2001.
[14]
J. Narbutt, A. Lesiak, C. Arkuszewska, A. Rychter, J. Fijuth, and A. Sysa-Jedrzejowska, “Effective treatment of recalcitrant Hailey-Hailey disease with electron beam radiotherapy,” Journal of the European Academy of Dermatology and Venereology, vol. 21, no. 4, pp. 567–568, 2007.
[15]
A. Kittridge, C. Wahlgren, R. Fuhrer, M. Zirwas, and T. Patton, “Treatment of recalcitrant Darier's disease with electron beam therapy,” Dermatologic Therapy, vol. 23, no. 3, pp. 302–304, 2010.